3rd Quarter - Report

THE ALS ASSOCIATION for THE ALS ASSOCIATION

Firm
Client
Income
—
Expenses
$25,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

-Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 (H.R.8295) --Requested that the House and Senate Appropriations LHHS Subcommittee provide at least $135 million for ALS research at NIH in fiscal year 2023 to attract the next generation of scientists, accelerate the discovery and development of new treatments and increase the number of ALS clinical trials. Requested at least $75 000,000 to implement the expanded access program established by the ACT for ALS Act (P.L. 117-79). Requested at least $10 million to continue the National ALS Registry and Biorepository in fiscal year 2023 to help identify risk factors for ALS to reduce the number of new cases, connect patients with clinical trials, conduct surveillance of incidence and prevalence and collect biospecimens that will lead to a better understanding of who may develop ALS. Requested funding to establish the Advanced Research Projects Agency for Health to fund new research into Amyotrophic Lateral Sclerosis. - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023 (H.R.8239) --Requested the House and Senate Appropriations Agriculture Subcommittee provide at least $25 million specifically for ALS research to the FDA Orphan Products Grants Program in fiscal year 2023 to to implement P.L. 117-79 to establish the FDA Rare Neurodegenerative Disease Grant Program which is authorized to provide grants for clinical trials for ALS and other neurodegenerative diseases.- - Department of Defense Appropriations Act, 2023 (H.R.8236) -- Requested the House and Senate Appropriations Defense Subcommittee provide at least $60 million for the ALS Research Program in fiscal year 2023 to allow the program to build on a solid foundation of promising preclinical research to increase the number of ALS clinical trials by funding its own early phase trials.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8236 (117th), H.R. 8239 (117th), H.R. 8295 (117th)

Medicare/Medicaid MMM

-Inflation Reduction Act (H.R. 5376) -- Provisions related to providing up to 12 weeks of paid family and medical leave; extending Medicare telehealth flexibilities beyond the COVID-19 public health emergency; the establishment Advanced Research Projects Agency for Health (ARPA-H); provisions related to extending marketplace subsidies under the Patient Protection and Affordable Care Act; and provisions related to an out-of-pocket maximum for Medicare beneficiaries' prescription drugs. Advancing Telehealth Beyond COVID-19 Act of 2021 (H.R. 4040) -- Provisions related to extension of Medicare flexibilities including originating site, allowance of occupational and physical therapists, speech-language pathologists, and audiologists to continue to provide services, allowance for qualified health centers and rural health clinics to serve as a distant site, behavioral services to continue to be provided via audio-only technology, and allowance of hospice physicians and nurse practitioners to complete patient recertification via telehealth. Additional provisions related to delay of in-person evaluation requirements for mental health services until January 1, 2025 or end of emergency period. -The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act (H.R. 2903 / S. 1512) Provisions related to the Centers for Medicare & Medicaid Services (CMS) to waive certain restrictions, such as geographic restrictions, for services provided in high-need health professional shortage areas; excludes mental health and emergency medical services, as well as services provided at rural health clinics, federally qualified health centers, and Indian Health Service facilities, from such geographic restrictions; and waive coverage restrictions during national emergencies. -Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act (H.R. 708 / S. 168) temporarily authorizes the interstate provision of in-person and telehealth services. This authorization applies during, and for at least 180 days after, the COVID-19 (i.e. coronavirus disease 2019) emergency. Specifically, subject to scope of practice and other requirements, a health care professional may provide health services in any U.S. jurisdiction based on that individual's authorization to practice in any one state or territory. The bill also provides certain related powers to health care professional regulatory bodies, such as medical boards. Specifically, a regulatory may investigate and take disciplinary actions against a processional who provides services pursuant to this bill to a patient in that body's jurisdiction. -CURES 2.0 Act (H.R. 6000) -- Provisions related to drug development, research, and access to emerging therapies for Americans with ALS and other rare diseases through the creation of ARPA-H and other mechanisms.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2903 (117th), H.R. 708 (117th), H.R. 4040 (117th), S. 168 (117th), H.R. 6000 (117th), S. 1512 (117th), H.R. 5376 (117th)

Health Issues HCR

-Promising Pathway Act (H.R. 3761/S. 1644) would create a provisional approval path for drugs and biological interventions that meet unmet needs of rare diseases like ALS. -CURES 2.0 Act (H.R. 6000) -- Provisions related to drug development, research, and access to emerging therapies for Americans with ALS and other rare diseases through the creation of ARPA-H and other mechanisms. - Inflation Reduction Act (H.R. 5376) -- Provisions related to providing up to 12 weeks of paid family and medical leave; extending Medicare telehealth flexibilities beyond the COVID-19 public health emergency; the establishment Advanced Research Projects Agency for Health (ARPA-H); provisions related to extending marketplace subsidies under the Patient Protection and Affordable Care Act; and provisions related to an out-of-pocket maximum for Medicare beneficiaries' prescription drugs. - Telehealth Modernization Act (H.R. 1332/S. 368) -- Provisions related to the modification of requirements relating to coverage of telehealth services under Medicare, including certain flexibilities that were initially authorized during the public health emergency relating to COVID-19. - HELP Copays Act (H.R.5801) -- Provisions related to health insurance plans requirement to apply payments made by or on behalf of plan enrollees toward a plan's cost-sharing requirements, i.e. a ban on copay-accumulator adjust programs.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th), H.R. 5801 (117th), H.R. 3761 (117th), H.R. 6000 (117th), S. 368 (117th), H.R. 1332 (117th), S. 1644 (117th)

Pharmacy PHA

- CURES 2.0 Act (H.R. 6000) -- Provisions related to drug development, research, and access to emerging therapies for Americans with ALS and other rare diseases through the creation of ARPA-H and other mechanisms. -Food and Drug Amendments of 2022 (H.R. 7667) / PDUFA VII-- provisions related to accelerated approval program, clinical trial diversity, novel clinical trial design and modeling, improving accountability and transparency of the FDA.

LobbyistCovered position, as disclosed
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6000 (117th), H.R. 7667 (117th)

Veterans VET

Justice for ALS Veterans Act (H.R. 5607 / S.3483) -- All Provisions, including those extending Dependency and Indemnity Compensation payments to surviving spouses of veterans who die from ALS, regardless of how long a veteran had ALS prior to death.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3483 (117th), H.R. 5607 (117th)

Family issues/Abortion/Adoption FAM

Inflation Reduction Act (H.R. 5376) -- Provisions related to providing up to 12 weeks of paid family and medical leave.

LobbyistCovered position, as disclosed
DENISE DEMICHELE-BAILIN —
KATHLEEN SHEEHAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Aviation/Airlines/Airports AVI

Air Carrier Access Amendments Act (H.R. 1619 / S. 642) -- provisions related to prohibiting discrimination against disabled individuals by an air carrier.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1619 (117th), S. 642 (117th)

Civil Rights/Civil Liberties CIV

- Air Carrier Access Amendments Act (H.R. 1619 / S. 642) -- provisions related to prohibiting discrimination against disabled individuals by an air carrier. - Disability Employment Incentive Act (H.R. 3765 / S. 630) - Provisions related to adding SSDI recipients to qualified Work Opportunity Tax Credits, doubling and extending the Work Opportunity Tax Credit, doubling the Disability Access Expenditures Tax Credit, and increasing the Architectural and Transportation Barrier Tax Credit.

LobbyistCovered position, as disclosed
DANIEL NOAH CRAMER —
DENISE DEMICHELE-BAILIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3765 (117th), H.R. 1619 (117th), S. 630 (117th), S. 642 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.